Madison, WI, United States of America

Aparajita Sarkar


Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Aparajita Sarkar in Cancer Therapy

Introduction

Aparajita Sarkar is an accomplished inventor based in Madison, WI (US), known for her significant contributions to cancer therapy through innovative polyamine compounds. With a total of four patents to her name, she has made strides in the field of medical research, particularly in developing methods for treating diseases characterized by abnormal cell proliferation.

Latest Patents

Sarkar's latest patents include groundbreaking work on cycloalkyl substituted polyamines for cancer therapy. These conformationally restricted polyamine compounds are designed to be useful in the treatment of cancer and other diseases marked by abnormal cell proliferation. The patents also disclose improved methods for synthesizing these compounds. One notable method involves reacting a carbene-bearing or carbene equivalent-bearing compound with the double bond of an alkene compound to form a cyclopropyl ring, which serves as the first step in the synthesis process.

Career Highlights

Throughout her career, Aparajita Sarkar has worked with various companies, including Cellgate, Inc. Her work has been pivotal in advancing the understanding and treatment of cancer, showcasing her dedication to medical innovation.

Collaborations

Sarkar has collaborated with notable professionals in her field, including Aldonia L Valasinas and Andrei V Blokhin. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Aparajita Sarkar's innovative work in cancer therapy exemplifies the impact of dedicated research and development in the medical field. Her patents and collaborations highlight her commitment to improving treatment options for patients facing serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…